Xenical is an innovative weight loss medication, ideal for those on a journey to reduce their weight. Its active ingredient, Orlistat, is specially formulated to bind with dietary fat, reducing the body's absorption of fat by approximately one-third. This unique action assists in more effective weight loss, making Xenical a preferred choice for individuals with a Body Mass Index (BMI) over 30, or over 28 with additional health concerns like high blood pressure or diabetes.

Key Features:

• Contains Orlistat, a proven fat-binding drug.
• Reduces fat absorption from food by about 30%.
• Clinically proven to aid in weight loss and maintenance.
• Suitable for individuals with a BMI of over 30, or over 28 with additional health conditions.
• Easy to use: one capsule three times a day with meals.
• Trusted worldwide, with millions of users.

Frequently Asked Questions (FAQs):

Is this an over-the-counter medication?

No, this is a prescription-only medication that can be purchased over the counter via a private service called PGD (Patient Group Direction).

What are the service inclusion criteria?

Xenical is suitable for a specific group of individuals who meet the following criteria:

1. Age Range: People aged between 18 and 65 years.
2. BMI Threshold: People with an initial Body Mass Index (BMI) of 30 kg/m² or greater qualify for Xenical.
3. Failed Previous Weight Management Attempts: This treatment is intended for people for whom prior attempts at weight reduction, including supervised diet, behaviour modification, and increased physical activity, have not resulted in a practical and sustainable reduction in weight.
4. Weight-Related Comorbidities: People with an initial BMI of 28 kg/m² or greater are also eligible if they have at least one weight-related comorbidity. These comorbidities may include, but are not limited to:
   • Controlled Hypertension
   • Dyslipidaemia
   • Obstructive sleep apnoea
   • Type 2 diabetes mellitus

What will happen once I have answered the questions in the form?

A pharmacist trained to provide this private service will assess the form and call you to discuss the answers you provided with you.

Why do I need to provide my phone number?

In order to dispense this medication without a prescription, the consultation must be carried out via phone or video call. As well as this being a legal requirement to ensure that the medication is suitable for you, the final phone consultation will allow you to ask any questions you may have to the pharmacist.

Is the consultation private?

Patient confidentiality is one of our top priorities, both the form you fill and the phone consultation are strictly confidential between you and the pharmacist.

Do I need to pay for the consultation?

The price you see is inclusive of the consultation fee, so you will not have to pay anything extra.

Please note

We may need to identify the intended user with an identity check. More information about this will be provided during the consultation.

• Over The Counter (OTC)

Active ingredient: 120 mg orlistat

Other ingredients:

Capsule filling: microcrystalline cellulose (E460), sodium starch glycolate (type A), povidone (E1201), sodium laurilsulfate, talc. Capsule shell: gelatine, indigo carmine (E132), titanium dioxide (E171), edible printing ink (black iron oxide, ammonia solution concentrated, potassium hydroxide, shellac, propylene glycol).

One 120 mg capsule should be taken orally with water immediately before, during or up to one hour after each main meal, for a maximum of three times a day.

A tablet should not be taken if a meal is missed or contains no fat.

• Not recommended with ciclosporin.
• Adherence to dietary recommendations is essential.
• High-fat diets increase the risk of gastrointestinal side effects.
• Additional contraception is advised during severe diarrhoea.
• Risk of hyperoxaluria and oxalate nephropathy, potentially leading to renal failure.
• Possible hypothyroidism or reduced control of it; may affect iodine salts/levothyroxine absorption.
• May decrease absorption of antiepileptic drugs, leading to convulsions.
• Potential reduction in absorption and efficacy of HIV antiretrovirals.
• Contains less than 1 mmol sodium per capsule ('sodium-free').

Contraindications

• Hypersensitivity to active substance or excipients.
• Chronic malabsorption syndrome.
• Cholestasis.
• Breast-feeding.